Sugi Predict

Sugi Predict / Compounds / SCHEMBL2863158

SCHEMBL2863158

SCHEMBL2863158

COc1cc(OC)c2c(c1)[nH]c(=O)c1c(N)n(-c3ccccc3C)nc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 1/20 0.43
▸ PDE5A O76074 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TP53 P04637 2/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ BRD4 O60885 2/20 0.35
▸ PARP1 P09874 2/20 0.35
▸ PDE3B Q13370 2/20 0.35
▸ PDE3A Q14432 2/20 0.35
▸ MAPK14 Q16539 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856187 0.90 ABCG2 (0.38) ABCG2PDE5AKMT2AKDM4EALDH1A1
SCHEMBL2862702 0.90 SCN9A (0.39) ABCG2PDE5AHTTKMT2ATP53
SCHEMBL2871102 0.89 MMP13 (0.38) ABCG2PDE5AHTTKMT2AADORA3
SCHEMBL2858318 0.89 PDE2A (0.35) ABCG2PDE5AHTTKMT2ATP53
SCHEMBL2861869 0.89 HIF1A (0.40) ABCG2HTTKMT2ATP53HIF1A
SCHEMBL2865147 0.88 BRD4 (0.36) ABCG2PDE5AHTTKMT2ATP53
SCHEMBL2863760 0.88 MPO (0.37) PDE5AHTTKMT2AKDM4EBRD4
SCHEMBL2860707 0.88 BTK (0.42) ABCG2PDE5AKMT2AALDH1A1NR1H4
SCHEMBL2861485 0.87 APEX1 (0.35) ABCG2PDE5AHTTKMT2ATP53
SCHEMBL13025356 0.87 KDM4E (0.39) PDE5AHTTKMT2AKDM4EBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-7842701-B2 Pyrazoloquinolone derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-11-30 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof TAKEDA PHARMACEUTICAL COMPANY (JP) 2007-12-06 — — US disclosed
EP-1719771-A1 PYRAZOLOQUINOLONE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2006-11-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281963-A1 Pyrazoloquinolone Derivative And Use Thereof MAP3K20, MAP4K5, MAP4K3 ABCG2 817/4885PDE5A 1718/4885HTT 3876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.